The Importance of Early and Accurate Diagnosis and Treatment of ILD and IPF

This webinar is provided by National Jewish Health  

This educational activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Webinar Overview

The goal of this online program is to improve health care providers’ knowledge, competence and performance to close gaps related to early guideline-concordant diagnosis, management, and treatment of patients with Interstitial Lung Diseases (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Topics included in the program are the natural history of IPF/ILD, early and accurate guideline-based diagnosis, differentiating IPF from other Interstitial Lung Diseases (ILD), and early initiation of treatment to improve patient outcomes.

Date and Time

This webinar will be held on three separate days

• Tuesday, September 15, 2020 7:00 PM – 8:30 PM EDT
• Tuesday, September 22, 2020 7:00 PM – 8:30 PM EDT
• Wednesday, October 7, 2020 7:00 PM – 8:30 PM EDT

Learning Objectives

• Integrate new information about the natural history of IPF and other ILDs into clinical decision-making and discussions with patients about their prognosis.
• Employ best practices for the early and accurate diagnosis of IPF and other ILDs.
• Develop pharmacologic and non-pharmacologic treatment plans for patients with IPF that help to preserve lung function and manage symptoms.

CME/CE credit provided